Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
Epiminder entered the red-screen conversation after the biggest-loser screener showed EPI down -4.4% at A$0.330. That is the sort of move that can pull a small or specialist ASX name from the edge of a watchlist into the centre of the daily debate. The …
EZZ Life Science (ASX:EZZ)entered the red-screen conversation after the biggest-loser screener showed EZZ down -3.7% at A$0.395. That is the sort of move that can pull a small or specialist ASX name from the edge of a watchlist into the centre of the daily …
The stock appeared on the Australian biggest losers list, with volume of not publicly available and relative volume of not publicly available. Relative volume matters because it hints at whether the session was unusually active or simply a thinly traded decline.
The stock appeared on the Australian biggest losers list, with volume of 93.52K and relative volume of 1.27. Relative volume matters because it hints at whether the session was unusually active or simply a thinly traded decline.
Austco Healthcare is a healthcare technology company supplying clinical communication and patient-care systems. Its listed sector context is Health technology / healthcare communications, which helps explain why the market can treat it differently from a bank, retailer or mature dividend payer. Investors are not …
• Tetratherix (ASX: TTX) gained 2.42% in the latest trading session, bringing the biotechnology company back onto investors' watchlists.
SomnoMed (ASX:SOM) has attracted renewed investor attention after gaining 2.83% during the latest trading session. The move has returned the sleep technology company to investors' watchlists as healthcare innovation continues to attract interest across the ASX.
OncoSil Medical (ASX: OSL) has returned to investors' watchlists after surging 23.08% during the latest trading session. The sharp rise placed the biotechnology company among the day's strongest-performing ASX stocks and renewed market interest in the healthcare sector.
4DMedical Limited (ASX:4DX) has reached a significant regulatory milestone with the approval of its CT:VQ™ imaging software by the Therapeutic Goods Administration (TGA), enabling commercial deployment across Australia. The announcement comes as the company’s shares traded atAUD 4.42, reflecting a 3.28% decline during the …
• Telix Pharmaceuticals (ASX:TLX) appears in the large-cap Australian companies screen with a market capitalisation of about 5.34 B AUD in the snapshot used for this article.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…